Cell type- and state- resolved immune transcriptomic profiling identifies glucocorticoid-responsive molecular defects in multiple sclerosis T cells
Tina Roostaei, Afsana Sabrin, Pia Kivisäkk, Cristin Aubin, Parham Nejad, Daniel Felsky, Hanane Touil, Ioannis S. Vlachos, Daniel Hui, Jennifer Fransson, Nikolaos A. Patsopoulos, Vijay Kumar Kuchroo, Violetta Zujovic, Howard L. Weiner, Hans‐Ulrich Klein, Philip L. De Jager
The paper identifies glucocorticoid-responsive molecular defects in MS T cells through cell-type-specific transcriptomic profiling and validates potential therapeutic targets.
bioRxiv · Jun 29, 2022 · PreprintGenomics